Qlife raises loans of SEK 15 million to strengthen working capital ahead of the upcoming market launch.
The Board of Directors of Qlife Holding AB has today entered into loan agreements of SEK 15 million.Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short. With the CE mark, Qlife's cost-effective, fast, and mobile PCR tests can be marketed and sold on the European market. The company is experiencing great interest in the European market launch as there is a growing and urgent need to carry out fast and reliable COVID-19 tests. To meet demand, Qlife intends to increase the pace and scale up capsule production. At the same time, the Company